Penn Medicine Provider
Hematology
James Eric Russell, MD
4.9
(58)
Accepting new patients
Sees patients age 18 and up
Penn Blood Disorders Center

About me

  • Associate Professor of Medicine (Hematology-Oncology)

Education and training

  • Medical School: Stanford University School of Medicine
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

58 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
i would highly recommend this provider
March 2025
5.0
5.0
he's a great doctor! i wouldn't recommend anyone to go to anyone else for their hematology/oncology needs.
March 2025
5.0
5.0
very caring and knowledgeable
January 2025
5.0
5.0
excellent care. explained everything in detail

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Russell is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Jiang, Y., Xu, X.-S., and Russell, J.E. The high stability of [beta]-globin mRNA requires site-specific binding of factors that remodel the structure of its 3'UTR. , The 8th Cooley's Anemia Symposium, New York Academy of Sciences, March 17-19: 2005


Jiang, Y., Xu, X.-S., and Russell, J.E. The high stability of human [beta]-globin mRNA is determined by a specific cis-element within its 3'UTR. , 28th Annual Meeting of the National Sickle Cell Disease Program, Cincinnati, April 9-13: 2005


He, Z., and Russell, J.E. Evidence that differential stabilization of [beta]-like globin mRNAs is mediated by specific determinants in their 3'UTRs. , 28th Annual Meeting of the National Sickle Cell Disease Program, Cincinnati, April 9-13: 2005


Russell, J.E. Adaptive post-transcriptional processes mitigate globin chain imbalance in [beta]-thalassemic erythrocytes , 27th Annual Meeting of the National Sickle Cell Disease Program, Los Angeles, April 18-21: 2004


He, Z., and Russell, J.E. Co-expression of human [zeta] globin corrects the sickle phenotype in mouse models of sickle cell disease , 27th Annual Meeting of the National Sickle Cell Disease Program, Los Angeles, April 18-21: 2004


Frehm, E.J., Russell, J.E., and Gow, A.J. Genetic and pharmacologic modulation of nitric oxide-hemoglobin reactivity , Eastern Society for Pediatric Research, Old Greenwich CT, March 26-28: 2004


Russell, J.E. Hemoglobinopathies and thalassemias. , Medical Knowledge Self-Assessment Program 13: 2003,30-32


View all publications